Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option

Insulet Corporation (NASDAQ:PODD) is one of the oversold stocks to buy right now. On June 3, Insulet launched significant enhancements to its Omnipod 5 Automated Insulin Delivery/AID System in the US, featuring a new 100 mg/dL Target Glucose option. This update allows for greater personalization and improved glycemic control, enabling users to increase their time in range with fewer system interruptions during high glucose events. The rollout is currently underway, with compatible Pods already shipping to retail channels.

Expanding its commitment to user choice and system flexibility, Insulet has also integrated the Omnipod 5 with Abbott’s FreeStyle Libre 3 Plus sensor. This compatibility allows for broader sensor options and includes support for the LibreLinkup app, facilitating easier tracking for caregivers. These updates represent the most substantial algorithm advancement for the platform since its 2022 launch, reinforcing the company’s focus on reducing the daily burden of diabetes management.

Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option

Insulet Corporation (NASDAQ:PODD) plans to present further details regarding these advancements at the American Diabetes Association’s 86th Scientific Sessions in New Orleans. By offering more flexible target settings and wider sensor integration, the company aims to remove barriers to AID technology and improve outcomes for people with type 1 and type 2 diabetes. Additional international rollouts for these features are expected to follow later this year.

Insulet Corporation (NASDAQ:PODD) is a medical device company focused on developing, manufacturing, and selling insulin delivery systems for patients with diabetes.

While we acknowledge the risk and potential of PODD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PODD and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1